2023-07-19T00:51:11Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:11Z
ENA-LAST-UPDATE
SAMN31740242
External Id
GSM6732456
External Id
2023-07-19T00:51:11Z
INSDC first public
2023-07-19T00:51:11Z
INSDC last update
public
INSDC status
SRS15765571
SRA accession
GSM6732456
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD8+
cell type
missing
collection_date
human
common name
male
gender
missing
geo_loc_name
9.09%
infusion percent_cd4
80%
infusion percent_cd8
1.13E+11
number til_infused
Homo sapiens
organism
107
overall survival_months
1
pfs censor_at_12_months
3
pfs months
PD
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
0
survival censor
TIL ACT Product
tissue
Patient 7 CD8+ [Pt07_CD8 RNA-seq]
title
TIL ACT
treatment
15781
trial